HCFA (Health Care Financing Administration) rules no change on pacemaker policy
This article was originally published in Clinica
The Health Care Financing Administration (HCFA) has decided not to change Medicare's pacemaker coverage policy. The federal health plan for the elderly and disabled currently pays for pacemaker implantation for patients with symptomatic bradycardia. But it refuses to cover the procedure for post myocardial infarction patients who might benefit from beta blocker drugs but cannot receive the medication because of asymptomatic bradycardia or those patients who take the drugs and later develop asymptomatic bradycardia as a result of the treatment.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.